Literature DB >> 32020412

The protective effect of platelet-rich plasma administrated on ovarian function in female rats with Cy-induced ovarian damage.

Pinar Ozcan1,2, Taha Takmaz3, Olgu Enis Tok4, Sevde Islek3, Esra Nur Yigit5, Cem Ficicioglu6.   

Abstract

PURPOSE: We evaluated the protective effect of PRP on ovarian function in female rats with cyclophosphamide (Cy)-induced ovarian damage.
METHODS: Thirty-two adult female Sprague-Dawley rats were randomly divided into four groups. Group 1 (control-sodium chloride 0.9%; 1 mL/kg, single-dose ip injection), group 2 (Cy); 75 mg/kg, single-dose ip injection and sodium chloride 0.9% (1 mL/kg, single-dose ip injection), group 3 Cy plus PRP, Cy (75 mg/kg, single-dose and PRP (200 μl, single-dose) ip injection), group 4 (PRP, 200 μl, single-dose ip injection). Primordial, antral, and atretic follicle counts; serum anti-Müllerian hormone (AMH) levels; AMH-positive granulosa cells; and gene expression analysis of Ddx4 were assessed.
RESULTS: Serum AMH levels were significantly lower in group 2 compared to groups 1, 3, and 4 (p < 0.01, p < 0.01, and p = 0.04, respectively). A significant difference was found in the primordial, primary, secondary, antral, and atretic follicle counts between all groups (p < 0.01). There was a statistically significant difference in AMH-positive staining primary, secondary, and antral follicles count between the groups (p < 0.01). There was a statistically significant difference in primary, secondary, and antral AMH positive staining follicle intensity score between the groups (p < 0.01). Ddx4 expression in group 4 was highest compared to other groups.
CONCLUSION: Our study may provide evidence that PRP could protect ovarian function against ovarian damage induced by Cy. It could lead to improved primordial, primary, secondary, and antral follicle numbers.

Entities:  

Keywords:  Follicle; Ovarian failure; Ovary; Platelet-rich plasma; Stereology

Mesh:

Substances:

Year:  2020        PMID: 32020412      PMCID: PMC7183018          DOI: 10.1007/s10815-020-01689-7

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  42 in total

Review 1.  Prevention of chemotherapy-induced ovarian damage.

Authors:  Hadassa Roness; Oren Kashi; Dror Meirow
Journal:  Fertil Steril       Date:  2015-12-08       Impact factor: 7.329

2.  Platelet-rich plasma: Growth factor enhancement for bone grafts.

Authors:  R E Marx; E R Carlson; R M Eichstaedt; S R Schimmele; J E Strauss; K R Georgeff
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1998-06

Review 3.  Musculoskeletal applications of platelet-rich plasma: fad or future?

Authors:  Kenneth S Lee; John J Wilson; David P Rabago; Geoffrey S Baer; Jon A Jacobson; Camilo G Borrero
Journal:  AJR Am J Roentgenol       Date:  2011-03       Impact factor: 3.959

4.  Intra-articular Injection of Mesenchymal Stem Cells and Platelet-Rich Plasma to Treat Patellofemoral Osteoarthritis: Preliminary Results of a Long-Term Pilot Study.

Authors:  Julien Pintat; Alain Silvestre; Guy Magalon; Alain Pierre Gadeau; Lionel Pesquer; Anne Perozziello; Alain Peuchant; Charbel Mounayer; Benjamin Dallaudière
Journal:  J Vasc Interv Radiol       Date:  2017-10-12       Impact factor: 3.464

Review 5.  The potential of topical and injectable growth factors and cytokines for skin rejuvenation.

Authors:  Sabrina Fabi; Hema Sundaram
Journal:  Facial Plast Surg       Date:  2014-05-08       Impact factor: 1.446

6.  Cyclophosphamide triggers follicle activation and "burnout"; AS101 prevents follicle loss and preserves fertility.

Authors:  Lital Kalich-Philosoph; Hadassa Roness; Alon Carmely; Michal Fishel-Bartal; Hagai Ligumsky; Shoshana Paglin; Ido Wolf; Hannah Kanety; Benjamin Sredni; Dror Meirow
Journal:  Sci Transl Med       Date:  2013-05-15       Impact factor: 17.956

7.  Protection against cisplatin-induced ovarian damage by the antioxidant sodium 2-mercaptoethanesulfonate (mesna) in female rats.

Authors:  John Yeh; Beom Su Kim; Jennifer Peresie
Journal:  Am J Obstet Gynecol       Date:  2008-04       Impact factor: 8.661

8.  Chemotherapy-induced ovarian failure as a prototype for acute vascular toxicity.

Authors:  Irit Ben-Aharon; Israel Meizner; Tal Granot; Shiri Uri; Noa Hasky; Shulamith Rizel; Rinat Yerushalmi; Aaron Sulkes; Salomon M Stemmer
Journal:  Oncologist       Date:  2012-09-06

9.  Novel methods of treating ovarian infertility in older and POF women, testicular infertility, and other human functional diseases.

Authors:  Antonin Bukovsky
Journal:  Reprod Biol Endocrinol       Date:  2015-02-25       Impact factor: 5.211

10.  Conserved and divergent patterns of expression of DAZL, VASA and OCT4 in the germ cells of the human fetal ovary and testis.

Authors:  Richard A Anderson; Norma Fulton; Gillian Cowan; Shona Coutts; Philippa Tk Saunders
Journal:  BMC Dev Biol       Date:  2007-12-18       Impact factor: 1.978

View more
  4 in total

Review 1.  Ovarian response to intraovarian platelet-rich plasma (PRP) administration: hypotheses and potential mechanisms of action.

Authors:  Serin Seckin; Hadi Ramadan; Marco Mouanness; Michelle Kohansieh; Zaher Merhi
Journal:  J Assist Reprod Genet       Date:  2022-02-17       Impact factor: 3.412

2.  Effects of Intraovarian Injection of Autologous Platelet-Rich Plasma on Ovarian Rejuvenation in Poor Responders and Women with Primary Ovarian Insufficiency.

Authors:  Abbas Aflatoonian; Marzieh Lotfi; Lida Saeed; Nasim Tabibnejad
Journal:  Reprod Sci       Date:  2021-03-08       Impact factor: 3.060

3.  Reactivating Ovarian Function through Autologous Platelet-Rich Plasma Intraovarian Infusion: Pilot Data on Premature Ovarian Insufficiency, Perimenopausal, Menopausal, and Poor Responder Women.

Authors:  Konstantinos Sfakianoudis; Mara Simopoulou; Sokratis Grigoriadis; Agni Pantou; Petroula Tsioulou; Evangelos Maziotis; Anna Rapani; Polina Giannelou; Nikolaos Nitsos; Georgia Kokkali; Michael Koutsilieris; Konstantinos Pantos
Journal:  J Clin Med       Date:  2020-06-10       Impact factor: 4.241

4.  Appraisal of Experimental Methods to Manage Menopause and Infertility: Intraovarian Platelet-Rich Plasma vs. Condensed Platelet-Derived Cytokines.

Authors:  E Scott Sills; Samuel H Wood
Journal:  Medicina (Kaunas)       Date:  2021-12-21       Impact factor: 2.430

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.